NOTCH3 细胞内结构域调节转录
中文名称
通路描述
在细胞核内,NICD3 与 RBPJ(CBF1, CSL)和 MAML(mastermind)蛋白 MAML1、MAML2 或 MAML3(可能还有 MAMLD1)形成复合物,即 NOTCH3 共激活复合物,激活 RBPJ 结合启动子元件的转录(Lin et al. 2002)。虽然 NOTCH1 偏好双 RBPJ 结合位点,但 NOTCH3 偏好单 RBPJ 结合位点(Ong et al. 2006)。NOTCH3 共激活复合物促进 HES1、HEYL、HES5 和 HEY2 等经典 NOTCH 靶基因的转录(Lin et al. 2002, Boelens et al. 2014, Maier and Gessler 2000, Geimer Le Lay et al. 2014, Lin te al. 2002, Shimizu et al. 2002, Wang et al. 2002)。NOTCH3 正调控前 T 细胞受体α链(PTCRA,即 pT-alpha 或 pre-TCRα)的转录(Talora et al. 2003, Bellavia et al. 2007)。IK1(转录因子 Ikaros 的剪接异构体,IKZF1)与 RBPJ 竞争结合 PTCRA 启动子并抑制 PTCRA 转录。NOTCH3 通过前 TCR 信号刺激 HuD RNA 结合蛋白的表达,促进 IKZF1 剪接为具有细胞毒活性的异构体。这些异质二聚化的 IKZF1 与 IK1 结合,阻止其与靶 DNA 序列结合,从而促进 PTCRA 的持续转录(Bellavia et al. 2007, reviewed by Bellavia, Mecarrozzi, Campese, Grazioli, Gulino and Screpanti 2007)。NOTCH3 触发的前 TCR 信号下调 TCF3(E2A)的活性,通过 ERK 依赖性诱导 ID1。抑制 TCF3 介导的转录下游于 NOTCH3 有助于转基因小鼠中 NICD3 表达导致的 T 细胞淋巴瘤的发生(Talora et al. 2003)。NOTCH3 下游 ERK 激活导致 TAL1 磷酸化,形成 TAL1:SP1 复合物,激活 CCND1 转录,促进细胞分裂(Talora et al. 2006)。NOTCH3 信号可通过前 TCR 信号间接或通过与 IKKA 结合直接激活 NF-κB(NFKB)介导的转录。NFKB 在来自 NOTCH3 转基因小鼠的 T 淋巴瘤细胞中持续活跃(Vacca et al. 2006)。PLXND1 基因(编码半导引素受体 Plexin D1)的转录直接由 NOTCH1 和 NOTCH3 共激活复合物刺激(Rehman et al. 2016)。FABP7(BLBP)在径向胶质细胞中的表达在神经迁移过程中由 NOTCH1 和 NOTCH3 正调控(Anthony et al. 2005, Keilani and Sugaya 2008)。NOTCH3 基因在卵巢癌中频繁扩增(Park et al. 2006)。NOTCH3 共激活复合物直接刺激 DLGAP5 转录。DLGAP5 参与 G2/M 转换,在卵巢癌细胞中过表达(Chen et al. 2012)。另一个在卵巢癌中过表达的基因 PBX1 的转录直接由 NOTCH3 刺激(Park et al. 2008)。NOTCH3 共激活复合物直接刺激 WWC1 基因转录。WWC1 基因编码蛋白 Kibra,参与 Hippo 信号通路。NOTCH3 诱导 WWC1 正调控 Hippo 信号通路并抑制三阴性乳腺癌细胞中的上皮 - 间质转化(EMT)(Zhang et al. 2016)。
英文描述
Antigen processing: Ub, ATP-independent proteasomal degradation Intracellular foreign or aberrant host proteins are cleaved into peptide fragments of a precise size, such that they can be loaded on to class I major histocompatibility complex (MHC I) molecules and presented externally to cytotoxic CD8+ T lymphocytes (CTLs) (reviewed by Embgenbroich M & Burgdorf S 2018). In the cytosol, CTL-recognized peptides are generated by proteasomes, which exist as a mixture of compositionally distinct complexes (reviewed by Kloetzel PM 2004; Habib JA et al., 2022). The proteasome complex consists of 20S proteolytic core particle (CP) associated with a regulatory particle (RP) such as 19S RP or PA28 RP (Zhao J et al. 2022; Adolf F et al., 2024; reviewed by Watanabe A et al., 2022). The catalytic subunits PSMB6 (β1), PSMB7 (β2), and PSMB5 (β5) within 20S CP exhibit caspase-like, trypsin-like, and chymotrypsin-like activities, respectively (Vigneron N et al. 2015; Rut W & Drag M 2016). During peptide bond cleavage, threonine from the active site of the catalytic β-subunit binds to the N-terminal peptide fragment forming an unstable acyl-enzyme intermediate, where a peptide fragment remains attached to the proteasome. Subsequently, a water molecule hydrolyzes the bond between the peptide and the proteasome, resulting in the release of the peptide's C-terminal end (Mishto M et al. 2012; Ebstein F et al. 2016; Soh WT et al., 2024). Either one or two regulatory particles (RP) can attach to the 20S CP (Zhao J et al. 2022; Adolf F et al., 2024; reviewed by Watanabe A et al., 2022). The 19S RP binds 20S CP to form the 26S proteasome, which degrades both foreign and self-proteins in the ubiquitin (Ub)- and ATP-dependent manner (Zhu Y et al., 2018; Dong Y et al., 2019; Zhang S et al., 2022; reviewed by Sahu I & Glickman MH 2021a). In addition, a subset of intracellular proteins, especially intrinsically disordered proteins, can directly bind to 20S CP for Ub- and ATP-independent proteasomal degradation (Makaros Y et al., 2023; Mamrosh JL et al., 2023; Pepelnjak M et al., 2024; reviewed by Sahu I & Glickman MH 2021 b; Bialek W et al., 2023). Unlike 19S, the PA28 regulatory particle does not have a ubiquitin receptor; binding of PA28 to the 20S CP promotes Ub-, ATP-independent protein breakdown. PA28 proteasomes are thought to be important for rapid degradation of misfolded proteins under conditions of oxidative stress or degradation of proteins with intrinsically disordered regions (Habib JA et al., 2020; Chen J et al., 2021; Zhao J et al. 2022; reviewed by Thomas T et al. 2023). Various immune cells, such as T cells, B cells, and antigen-presenting cells, constitutively express a specialized form of proteasomes, known as immunoproteasomes, in which the catalytic subunits PSMB6 (β1), PSMB7 (β2), and PSMB5 (β5) of 20S CP are substituted with PSMB9 (β1i), PSMB10 (β2i), and PSMB8 (β5i), respectively (Shin EC et al., 2006; Bai M et al., 2014; Santos R et al., 2017). This variation of the core particle is known as 20S iCP. Immunoproteasomes utilize the PA28 regulatory particle to degrade antigens (Lesne J et al., 2020; Chen J et al., 2021). Under inflammatory conditions, the expression of the catalytic and PA28 regulatory subunits of immunoproteasome is induced by cytokines like interferon-gamma (IFNγ), type I interferons, and tumor necrosis factor alpha (TNF-α). Immunoproteasomes possess enhanced chymotrypsin- and trypsin-like activities, alongside with the reduced caspase-like activity. These distinct enzymatic properties of immunoproteasomes generate substrate cleavage patterns that enhance loading of peptides onto the class I MHC for immune presentation to CTL (reviewed by Tomko RJ and Hochstrasser M 2013).This Reactome module describes Ub-independent antigen processing by PA28-20S CP and PA28-20S iCP proteasomes.
所含基因
19 个基因